Research

Awards, honors and achievements for the month of September.

Most health policy experts don’t think new Medicaid work requirements introduced in the One Big Beautiful Bill Act would substantially increase employment among Medicaid-enrolled, working-age adults, according to a new survey from the Cornell Health Policy Insight Panel.

Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus have received a $5.1 million, three-year grant from the National Institutes of Health’s Autism Data Science Initiative (ADSI) to launch the Autism Replication, Validation, and Reproducibility (AR²) Center.

The National Institute on Drug Abuse renewed CHERISH as a national Center of Excellence, awarding the center $10.9 million over five years to address the epidemics of substance use disorder, hepatitis C virus and HIV.

A new tool greatly improves scientists’ ability to identify and study proteins that regulate gene activity in cells, according to research led by Weill Cornell Medicine investigators.

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.

The award recognizes Dr. Nathan’s outstanding contributions that have advanced scientists’ understanding of the building blocks of innate immunity and how the immune system fights infectious diseases, including tuberculosis, and cancer.

“Kangaroo care,” or skin-to-skin contact, may be neuroprotective and is associated with neonatal development in areas of the brain involved in emotional regulation in preterm infants, according to a new preliminary study from Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine investigators.

Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine.

Weill Cornell Medicine has received a four-year, $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, for a study of the details and dynamics of the autoimmune process that causes type 1 diabetes.

Weill Cornell Graduate School of Medical Sciences doctoral student Ana Campos Codo has been selected for the 2025 cohort of the Gilliam Fellows Program by Howard Hughes Medical Institute (HHMI).

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

The award recognizes Dr. Greenblatt's discovery of distinct types of bone-building stem cells in different parts of the body. 

Along with an international team, Dr. John Moore, has brought biomedicine closer than ever to an HIV vaccine.

A scientific team co-led by Dr. Lishomwa Ndhlovu at Weill Cornell Medicine has received an NIH MERIT Award to provide long-term grant support to study several people who have managed to clear HIV after a stem cell transplant and those who did not.

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find ways to remove latent HIV from the cells of individuals with HIV.

Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut’s immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators.

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecelia Lira have been chosen to join the 2025 class of Pew scholars and fellows.

In this new role, Dr. Kaushal will help Weill Cornell Medicine harness data science opportunities in service of better patient outcomes.